Chemed Corporation (CHE)
NYSE: CHE · Real-Time Price · USD
429.54
-8.19 (-1.87%)
Dec 2, 2025, 4:00 PM EST - Market closed
Chemed Revenue
Chemed had revenue of $624.90M in the quarter ending September 30, 2025, with 3.09% growth. This brings the company's revenue in the last twelve months to $2.53B, up 6.45% year-over-year. In the year 2024, Chemed had annual revenue of $2.43B with 7.37% growth.
Revenue (ttm)
$2.53B
Revenue Growth
+6.45%
P/S Ratio
2.48
Revenue / Employee
$161,238
Employees
15,695
Market Cap
6.06B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.43B | 166.87M | 7.37% |
| Dec 31, 2023 | 2.26B | 129.45M | 6.06% |
| Dec 31, 2022 | 2.13B | -4.30M | -0.20% |
| Dec 31, 2021 | 2.14B | 59.68M | 2.87% |
| Dec 31, 2020 | 2.08B | 141.03M | 7.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
CHE News
- 20 days ago - Chemtrade Logistics Income Fund (CHE.UN:CA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Chemed Corporation (CHE) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 25 days ago - Chemed Corporation Declares Quarterly Dividend of 60 Cents - GlobeNewsWire
- 4 weeks ago - Chemed Corporation to Present at the UBS 2025 Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Schwartz Offloads 28,000 Chemed (CHE) Shares Valued at $13 Million - The Motley Fool
- 4 weeks ago - EULAV Asset Management Unloads $13 Million of Chemed (NYSE: CHE) Stock: Should Investors Sell Too? - The Motley Fool
- 4 weeks ago - Chemed Corporation (CHE) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Chemed Reports Third-Quarter 2025 Results - GlobeNewsWire